Alacrimia-choreoathetosis-liver dysfunction syndrome

A rare, genetic, inborn error of metabolism disorder characterized by global developmental delay, hypotonia, choreoathetosis, hypo-/alacrimia, and liver dysfunction which manifests with elevated liver transanimases and hepatocyte cytoplasmic storage material or vacuolization on liver biposy. Additional features reported include acquired microcephaly, hypo-/areflexia, seizures, peripheral neuropathy, intellectual and language/speech disability, additional ocular anomalies and EEG and brain imaging abnomalities.



Input patient's signs and symptoms


Narrow down the case reports



Total: 2 (papers)

  


(per page)
Matched Phenotype  Gene  Mutation  MeSH
Rank
(Similarity)
PMID
(PMCID)
1
(39.0%)
24651605
(4243708)
Mutations in NGLY1 cause an inherited disorder of the endoplasmic reticulum-associated degradation pathway.
Enns GM, Shashi V, Bainbridge M, Gambello MJ, Zahir FR, Bast T, Crimian R, Schoch K, Platt J, Cox R, Bernstein JA, Scavina M, Walter RS, Bibb A, Jones M, Hegde M, Graham BH, Need AC, Oviedo A, Schaaf CP, Boyle S, Butte AJ, Chen R, Chen R, Clark MJ, Haraksingh R, , Cowan TM, He P, Langlois S, Zoghbi HY, Snyder M, Gibbs RA, Freeze HH, Goldstein DB.
Genet Med. 2014;16(10):751-8.
Microcephaly
NGLY1
c|SUB|A|1201|T;RS#:201337954 p|SUB|R|401|X;RS#:201337954 rs1553666033 rs201337954 rs528583612 rs587776982 rs587777265 rs587777266 rs768131676
Child, Preschool Developmental Disabilities Endoplasmic Reticulum-Associated Degradation Exome Fatal Outcome Females Genome-Wide Association Study Homo sapiens Infant Male Microcephaly Movement Disorders Mutation Retrospective Studies Seizures Sequence Analysis, DNA Signal Transduction Young Adult
2
(4.0%)
30740912
Unexplained death in patients with NGLY1 mutations may be explained by adrenal insufficiency.
van Keulen BJ, Rotteveel J, Finken MJJ.
Physiol Rep. 2019;7(3):e13979.
Adrenal insufficiency
NGLY1 NRF1
c|DEL|1837| p|FS|Q|613||
Child Congenital Disorders of Glycosylation Females Genetic Predisposition to Disease Homo sapiens Homozygote Mutation Phenotype Proteostasis Proteostasis Deficiencies
        

Phenotype(s) retrieved from Orphanet

    Total: 89

HPO ID Term Frequency
HP:0002059 Cerebral atrophy Very frequent (99-80%)
HP:0002487 Hyperkinesis Very frequent (99-80%)
HP:0007141 Sensorimotor neuropathy Very frequent (99-80%)
HP:0000633 Decreased lacrimation Frequent (79-30%)
HP:0001249 Intellectual disability Frequent (79-30%)
HP:0001263 Global developmental delay Frequent (79-30%)
HP:0001272 Cerebellar atrophy Frequent (79-30%)
HP:0001344 Absent speech Frequent (79-30%)
HP:0001508 Failure to thrive Frequent (79-30%)
HP:0001518 Small for gestational age Frequent (79-30%)
HP:0002123 Generalized myoclonic seizures Frequent (79-30%)
HP:0002187 Intellectual disability, profound Frequent (79-30%)
HP:0002353 EEG abnormality Frequent (79-30%)
HP:0002376 Developmental regression Frequent (79-30%)
HP:0002465 Poor speech Frequent (79-30%)
HP:0002540 Inability to walk Frequent (79-30%)
HP:0002659 Increased susceptibility to fractures Frequent (79-30%)
HP:0002870 Obstructive sleep apnea Frequent (79-30%)
HP:0002910 Elevated hepatic transaminase Frequent (79-30%)
HP:0003563 Decreased LDL cholesterol concentration Frequent (79-30%)
HP:0003785 Decreased CSF homovanillic acid Frequent (79-30%)
HP:0012153 Hypotriglyceridemia Frequent (79-30%)
HP:0012447 Abnormal myelination Frequent (79-30%)
HP:0012450 Chronic constipation Frequent (79-30%)
HP:0025455 Decreased CSF 5-hydroxyindolacetic acid Frequent (79-30%)
HP:0025457 Decreased CSF protein Frequent (79-30%)
HP:0025458 Decreased CSF albumin concentration Frequent (79-30%)
HP:0040209 Decreased CSF biopterin level Frequent (79-30%)
HP:0000297 Facial hypotonia Occasional (29-5%)
HP:0000559 Corneal scarring Occasional (29-5%)
HP:0000657 Oculomotor apraxia Occasional (29-5%)
HP:0001265 Hyporeflexia Occasional (29-5%)
HP:0001332 Dystonia Occasional (29-5%)
HP:0001336 Myoclonus Occasional (29-5%)
HP:0001374 Congenital hip dislocation Occasional (29-5%)
HP:0001382 Joint hypermobility Occasional (29-5%)
HP:0001385 Hip dysplasia Occasional (29-5%)
HP:0001413 Micronodular cirrhosis Occasional (29-5%)
HP:0001414 Microvesicular hepatic steatosis Occasional (29-5%)
HP:0001744 Splenomegaly Occasional (29-5%)
HP:0001771 Achilles tendon contracture Occasional (29-5%)
HP:0001929 Reduced factor XI activity Occasional (29-5%)
HP:0002072 Chorea Occasional (29-5%)
HP:0002119 Ventriculomegaly Occasional (29-5%)
HP:0002121 Absence seizure Occasional (29-5%)
HP:0002171 Gliosis Occasional (29-5%)
HP:0002205 Recurrent respiratory infections Occasional (29-5%)
HP:0002240 Hepatomegaly Occasional (29-5%)
HP:0002305 Athetosis Occasional (29-5%)
HP:0002345 Action tremor Occasional (29-5%)
HP:0002421 Poor head control Occasional (29-5%)
HP:0002650 Scoliosis Occasional (29-5%)
HP:0002673 Coxa valga Occasional (29-5%)
HP:0002750 Delayed skeletal maturation Occasional (29-5%)
HP:0002909 Generalized aminoaciduria Occasional (29-5%)
HP:0003086 Acromesomelia Occasional (29-5%)
HP:0003121 Limb joint contracture Occasional (29-5%)
HP:0003447 Axonal loss Occasional (29-5%)
HP:0003834 Shoulder dislocation Occasional (29-5%)
HP:0004349 Reduced bone mineral density Occasional (29-5%)
HP:0005484 Postnatal microcephaly Occasional (29-5%)
HP:0005543 Reduced protein C activity Occasional (29-5%)
HP:0010819 Atonic seizures Occasional (29-5%)
HP:0010821 Gelastic seizures Occasional (29-5%)
HP:0011167 Focal tonic seizures Occasional (29-5%)
HP:0011900 Hypofibrinogenemia Occasional (29-5%)
HP:0011954 Nodular regenerative hyperplasia of liver Occasional (29-5%)
HP:0012201 obsolete Reduced prothrombin activity Occasional (29-5%)
HP:0012340 Decreased resting energy expenditure Occasional (29-5%)
HP:0012448 Delayed myelination Occasional (29-5%)
HP:0012469 Infantile spasms Occasional (29-5%)
HP:0020037 Astasia Occasional (29-5%)
HP:0025336 Delayed ability to sit Occasional (29-5%)
HP:0025401 Staring gaze Occasional (29-5%)
HP:0030194 Fatigable weakness of speech muscles Occasional (29-5%)
HP:0030906 Suck reflex Occasional (29-5%)
HP:0031008 Lingual dystonia Occasional (29-5%)
HP:0031051 Tarsal sclerosis Occasional (29-5%)
HP:0031146 Impaired oral bolus formation Occasional (29-5%)
HP:0031162 Impaired oropharyngeal swallow response Occasional (29-5%)
HP:0100899 Sclerosis of finger phalanx Occasional (29-5%)
HP:0000543 Optic disc pallor Very rare (4-1%)
HP:0000548 Cone/cone-rod dystrophy Very rare (4-1%)
HP:0000577 Exotropia Very rare (4-1%)
HP:0000580 Pigmentary retinopathy Very rare (4-1%)
HP:0000648 Optic atrophy Very rare (4-1%)
HP:0001488 Bilateral ptosis Very rare (4-1%)
HP:0011496 Corneal neovascularization Very rare (4-1%)
HP:0030001 Lagopthalmos Very rare (4-1%)


Phenotype(s) retrieved from case reports

    Total: 1

HPO ID Term # of case reports
HP:0000846 Adrenal insufficiency 1


Causative gene(s) retrieved from Orphanet

    Total: 1

Gene Symbol Gene Name Entrez Gene ID
NGLY1 N-glycanase 1 55768